Is Standard BioTools Inc. overvalued?

Standard BioTools Inc. (LAB) — key valuation metrics and fundamentals.

No verdict

Price

$0.71

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$278.9M

Dividend yield

0.0%

Return on equity

-18.2%

Sector

Healthcare

Fair value compares LAB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks